Ind-swift Laboratories
Ind-Swift Labs to sell pharma ingredients ops to Synthimed Labs for $198 mn
Ind-Swift Labs will sell its active pharmaceuticals ingredients (API) and contract research and manufacturing services (CRAMS) business
 "Ind-Swift Labs to sell pharma ingredients ops to Synthimed Labs for $198 mn")
Updated On : 06 Sep 2023 | 2:51 PM IST
PI Industries plunges 8% on termination of Ind-Swift slump sale agreement
The agreement had to be cancelled due to non-completion of several pre-agreed conditions precedents by Ind-Swift Labs
 "PI Industries plunges 8% on termination of Ind-Swift slump sale agreement")
Updated On : 02 Nov 2021 | 10:14 AM IST
Ind-Swift Lab zooms 83% in seven trading days on debt settlement hope
The stock is trading at its 52-week high of Rs 67.30, zooming 83% in past seven trading sessions from Rs 36.80 on December 14, 2017.
 "Ind-Swift Lab zooms 83% in seven trading days on debt settlement hope")
Updated On : 26 Dec 2017 | 1:55 PM IST
